AscellaHealth

AscellaHealth, based in Berwyn, Pennsylvania, extends its reach across the United States and Europe, operating as a global leader in Specialty Pharmacy and Healthcare services. This organization is committed to offering a robust spectrum of specialized, technology-enhanced pharmaceutical and medical management services catered specifically to the needs of payers, providers, life sciences companies, and patients. At the core of its operations is a patient-centric philosophy supported by proprietary technology, which drives the development of innovative programs and services. These efforts are aimed at improving health outcomes and enhancing the quality of life for individuals with complex, chronic conditions or rare diseases that require specialty medications, including advanced therapies like gene and cell treatments.

Dea Belazi, holding the titles of CEO and Co-founder, has been integral to AscellaHealth's ascent to a prominent position within the global Healthcare & Specialty Pharmacy (S.P.) solutions market. Under his guidance, the company has grown to employ over 200 professionals globally, providing cutting-edge, tailored solutions that enhance medication accessibility and patient outcomes, especially for those afflicted with specialty conditions or rare diseases. With a background as both a seasoned business leader and a Registered Pharmacist, Belazi has effectively aligned its comprehensive service offerings with the needs of pharmaceutical manufacturers and other stakeholders in the industry.

Bill Oldham, as Chairman, President, and Co-founder, has leveraged his extensive background in fintech to elevate AscellaHealth's stature within the Specialty Pharmacy sector. His leadership has driven the company to a significant 1556% revenue increase over four years, propelled by both organic growth and strategic acquisitions. Oldham's leadership and innovative contributions have not gone unnoticed, earning him prestigious recognitions such as the Philadelphia Business Journal's 2022 CFO of the Year and inclusion in the Philadelphia Titan 100 for 2023 and 2024.

About AscellaHealth: Better Data for Better Health

AscellaHealth integrates clinical, financial, and technological resources to streamline access to specialty medications, improving clinical outcomes and enhancing the treatment experience for patients with chronic or complex conditions requiring specialty pharmaceuticals, cell, and gene therapies. The company's expansive service offering includes Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, Proprietary Specialty Pharmacy and Infusion Network, Customized Clinical Programs, Technology-based Patient Engagement, Medical and Pharmacy Benefit Management, Drug Rebate Programs, and Real-Time Prescription Data and Analytics, all powered by AscellaHealth's proprietary technology platform.

AscellaHealth's Solutions

Life Sciences

AscellaHealth is the preferred launch partner for life sciences companies embarking on the commercialization of therapies for chronic, complex conditions. The company offers a comprehensive range of services that support these entities from the clinical trial phase through to ensuring patients successfully transition onto new therapies, encompassing distribution, patient support, and extensive data and analysis.

Payers & Health Plans

AscellaHealth provides a comprehensive suite of services that optimize patient outcomes and cost management for captives, self-insured entities, at-risk providers, PBMs, and regional health plans. The company's core offerings include specialty and medical cost management, formulary and network design, custom clinical programs, and detailed data analysis.

AscellaHealth's Innovation Is Widely Recognized

Recognized as a global leader in specialty pharmacy and healthcare services, AscellaHealth has received numerous awards and accolades for its innovative approach within and beyond the healthcare industry. Notable recognitions include the 2024 Top 10 Pharma & Life Science Solutions Providers and being named a top Pharmacy Management Solutions Provider by Health Tech Outlook in 2024.

About Dea Belazi

Dea Belazi, co-founder and visionary leader, has steered AscellaHealth to achieve significant industry recognition, including awards like The Financial Times Fastest Growing Company and Deloitte Fast 500. Belazi is a prominent figure in Philadelphia's business community, recognized with awards such as EY Entrepreneur of The Year® National Finalist and Titan 100. His academic background includes a PharmD from the University of Rhode Island, a Master of Public Health from Johns Hopkins University, and a post-doctoral fellowship in health outcomes research at Thomas Jefferson University.

About Bill Oldham

Bill Oldham, co-founder, brings nearly three decades of experience as an entrepreneur, investor, and consultant across the health, technology, financial, and energy sectors, significantly shaping AscellaHealth's trajectory. His innovative use of fintech within the PBM industry and his leadership in developing two $100-million companies exemplify his capacity for driving growth and innovation. Oldham started his career on Wall Street and has managed operations across continents, giving him a deep understanding of the global economy. He holds an MBA from Manchester Business School, specializing in entrepreneurship and venture finance, and a Blockchain Technologies certification from MIT Sloan School of Management.